Elsevier

Placenta

Volume 59, November 2017, Pages 124-130
Placenta

The application of decellularized human term fetal membranes in tissue engineering and regenerative medicine (TERM)

https://doi.org/10.1016/j.placenta.2017.07.002Get rights and content

Highlights

  • Fetal membranes are a valuable source of ECM-based biomaterial to expand and promote maturation of stem cells from different sources.

  • Decellularized fetal membranes can be processed into two/three dimensional scaffolds and cell/drug delivery particles to promote regeneration.

  • Decellularized fetal membranes can be used as a novel approach for cancer therapies.

  • Decellularized fetal membranes provide a platform to better understand the role of extracellular matrix in stem cell function.

Abstract

Tissue engineering and regenerative medicine (TERM) is a field that applies biology and engineering principles to “restore, maintain or repair a tissue after injury”. Besides the potential to treat various diseases, these endeavours increase our understanding of fundamental cell biology. Although TERM has progressed rapidly, engineering a whole organ is still beyond our skills, primarily due to the complexity of tissues. Material science and current manufacturing methods are not capable of mimicking this complexity. Therefore, many researchers explore the use of naturally derived materials that maintain important biochemical, structural and mechanical properties of tissues. Consequently, employing non-cellular components of tissues, particularly the extracellular matrix, has emerged as an alternative to synthetic materials. Because of their complexity, decellularized tissues are not as well defined as synthetic materials but they provide cells with a microenvironment that resembles their natural niche.

Decellularized tissues are produced from a variety of sources, among which the fetal membranes are excellent candidates since their supply is virtually unlimited, they are readily accessible with minimum ethical concerns and are often discarded as a biological waste. In this review, we will discuss various applications of decellularized fetal membranes as substrates for the expansion of stem cells, their use as two and three-dimensional scaffolds for tissue regeneration, and their use as cell delivery systems. We conclude that fetal membranes have great potential for use in TERM.

Section snippets

Fetal membranes

The human fetal membranes envelop the fetus and amniotic fluid to form a sac, which acts as an interface with the mother and protects the fetus during pregnancy [1], [2]. In the following sections, we summarize important aspects of the structure and properties of human fetal membranes, the various stem cell populations harboured in human fetal membranes, and briefly describe the history of use of fetal membranes as biomaterials.

Decellularization: exposing the extracellular matrix (ECM)

ECM surrounds all adherent cells in body; which is a complex network of different soluble and non-soluble biomolecules including proteins, glycoproteins and glycosaminoglycans (GAGs). Historically, the role of the ECM was perceived to be an anchor for cell attachment and for defining tissue shape, but there is increasing evidence that ECM regulates cell behaviours [31], [32]. ECM contributes to cellular functions through compositional, structural/organisational and mechanical properties [32],

Growth surfaces to enhance stem cell properties

Decellularized fetal membranes affect the differentiation potential and maturation of MSCs. MSCs grown on decellularized fetal membrane surfaces show greater potential for osteogenesis and adipogenesis depending on which side of the decellularized fetal membranes they are grow when compared with MSCs grown on tissue culture plastic (TCP). The stromal side of decellularized AM (dAM) stimulates differentiation into hard tissues such as bone, whereas the epithelial side of dAM is more efficient in

Conclusion

Decellularized fetal membranes show promise as surfaces to expand and promote maturation of stem cells from different sources, as 2D/3D scaffolds to improve regeneration and as cell/drug delivery particles. Despite the progress in manufacturing various structures from dAM, the applications of fetal membranes in tissue engineering are in their infancy and more research is needed to fully explore their potential. Attempts to solubilize fetal membranes will allow the production of more uniform

Acknowledgment

The authors want to acknowledge that parts of Fig. 1 were adapted from the artwork by Maurizio Fusillo from The Noun Project under the Creative Commons Corporation licence (https://creativecommons.org/licenses/by/3.0/legalcode). We would like to acknowledge the Selby Foundation, Equity Trustees, the Hallmark Therapeutic Technologies Research Initiative, and the Particulate Fluids Processing Centre for support.

References (43)

  • T.J. Keane et al.

    Methods of tissue decellularization used for preparation of biologic scaffolds and in vivo relevance

    Methods

    (2015)
  • P.M. Crapo et al.

    An overview of tissue and whole organ decellularization processes

    Biomaterials

    (2011)
  • Y.-J. Chen et al.

    The effects of acellular amniotic membrane matrix on osteogenic differentiation and ERK1/2 signaling in human dental apical papilla cells

    Biomaterials

    (2012)
  • S.-z. Ji et al.

    An epidermal stem cells niche microenvironment created by engineered human amniotic membrane

    Biomaterials

    (2011)
  • G.D. Bryant-Greenwood

    The extracellular matrix of the human fetal membranes: structure and function

    Placenta

    (1998)
  • J.A. Meierhenry et al.

    Placenta as a source of stem cells for regenerative medicine

    Curr. Pathobiol. Rep.

    (2015)
  • S.-P. Wilshaw et al.

    Production of an acellular amniotic membrane matrix for use in tissue engineering

    Tissue Eng.

    (2006)
  • G. Bourne

    The foetal membranes: a review of the anatomy of normal amnion and chorion and some aspects of their function

    Postgrad. Med. J.

    (1962)
  • O. Parolini et al.

    Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells

    Stem Cell.

    (2008)
  • N. Castrechini et al.

    Decidua parietalis-derived mesenchymal stromal cells reside in a vascular niche within the choriodecidua

    Reprod. Sci.

    (2012)
  • M. Evangelista et al.

    Placenta-derived stem cells: new hope for cell therapy?

    Cytotechnology

    (2008)
  • Cited by (22)

    • Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration

      2021, Materials Today Bio
      Citation Excerpt :

      ECM hydrogels may be used in the future as part of the treatment of Asherman's syndrome and endometrial atrophy (Table 1). The amnion membrane (AM), a prospective biomaterial, can not only act as a mechanical barrier that separates the wounded surface but also secrete various growth factors to activate the regulation of endometrial cell proliferation, migration, and differentiation, thereby achieving morphological and functional recovery of the uterus [79,80]. In the clinical setting, both the fresh and lyophilized AM have been used for IUA therapy [81,82].

    View all citing articles on Scopus
    1

    Authors with the same contribution to this paper.

    View full text